United Therapeutics reported a fourth-quarter net income of $364.3 million, or $7.70 a share, compared with $301.3 million, or $6.19 a share, a year earlier. The results beat Wall Street's forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results